Signaling Molecules in Overcirculation-Induced Pulmonary Hypertension in Piglets
- 12 October 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 110 (15), 2220-2225
- https://doi.org/10.1161/01.cir.0000143836.40431.f5
Abstract
Background— The phosphodiesterase type-5 (PDE-5) inhibitor sildenafil has been reported to improve pulmonary arterial hypertension (PAH), but the mechanisms that account for this effect are incompl...Keywords
This publication has 21 references indexed in Scilit:
- Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial HypertensionCirculation, 2003
- Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary HypertensionCirculation, 2003
- Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial HypertensionCirculation, 2003
- Signaling Molecules in Nonfamilial Pulmonary HypertensionNew England Journal of Medicine, 2003
- Antiangiogenic Effect of Angiotensin II Type 2 Receptor in Ischemia-Induced Angiogenesis in Mice HindlimbCirculation Research, 2002
- CLINICAL CLASSIFICATION OF PULMONARY HYPERTERNSIONClinics in Chest Medicine, 2001
- Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II GeneAmerican Journal of Human Genetics, 2000
- Development and Validation of Real-Time Quantitative Reverse Transcriptase–Polymerase Chain Reaction for Monitoring Gene Expression in Cardiac Myocytesin VitroAnalytical Biochemistry, 1999
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997